Your session is about to expire
← Back to Search
Custom 3D Printed Insoles for Diabetes Foot Health (3D Insole Trial)
3D Insole Trial Summary
This trial is testing if custom foot orthotics improve foot health and mobility for people who are at increased risk of developing foot ulcers, compared to those who don't wear them. The study involves up to 12 visits lasting up to 4 hours, and participants are paid for their time.
3D Insole Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria below3D Insole Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.3D Insole Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a prescription for diabetic foot supports.I am 18 years old or older.I cannot walk by myself.I need special footwear for my daily activities.I understand and can communicate effectively to consent.I have had a foot ulcer in the past month, healed or not.
- Group 1: Diabetic with elevated plantar pressure
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have been selected to participate in this clinical investigation?
"Absolutely. The clinical trial database reveals that this experiment, which was posted on March 1st 2022, is actively seeking volunteers. 25 participants need to be enrolled from one research centre."
Is there still room in this clinical trial for new participants?
"According to the information posted clinicaltrials.gov, recruitment for this medical study is ongoing. It was published on March 1st 2022 and had its most recent update on April 28th 2022."
Share this study with friends
Copy Link
Messenger